Arnaud D.
- Country
- Belgium
- Department
- nephrology
Research Overview
- Frexalimab Versus Tacrolimus for Prevention of Kidney Graft Rejection in Adult Kidney Transplant Recipients
- Efficacy and Safety Evaluation of Inaxaplin (VX-147) in APOL1-Mediated Proteinuric Kidney Disease: A Phase 2/3 Adaptive, Double-Blind, Placebo-Controlled Study
- Investigation of Pharmacokinetic Variability of Tacrolimus Monohydrate and Mycophenolate Mofetil in Chronic Renal Failure Post-Kidney Transplantation
Data & Insights
Has run more than one trial at 4 of 63 partner sites.
Specializations
Kidney Disease Management
This investigator specializes in treating APOL1-mediated proteinuric kidney disease, focusing on innovative therapeutic approaches for patients with genetic kidney disorders.
- Genetic kidney disorders
- Proteinuric conditions
- APOL1-related nephropathy
Their work addresses targeted treatments for specific genetic variants affecting kidney function.
Transplant Medicine
The investigator focuses on kidney transplantation and post-transplant care, with particular attention to immunosuppressant therapy and its relationship with gut microbiota.
- Immunosuppressant pharmacokinetics
- Microbiome studies
- Chronic renal failure management
Their research explores the complex interactions between transplant medications and patient physiology.
Metabolic Disorders
The investigator conducts research in primary hyperoxaluria Type 1, examining therapeutic interventions for patients both with and without dialysis requirements.
- Oxalate metabolism disorders
- Dialysis therapy optimization
- Rare metabolic diseases
Their work encompasses treatment strategies for advanced metabolic kidney disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.